Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
yargesa
piramal critical care b.v. - miglustaattia - gaucherin tauti - muut ruuansulatuselimistön sairauksien ja aineenvaihduntasairauksien lääkkeet, - yargesa on tarkoitettu suun hoito aikuisten lievän ja keskivaikean tyypin 1 gaucher ' n tautia. yargesa voidaan käyttää vain potilaille, joille entsyymikorvaushoito ei sovi. yargesa on tarkoitettu hoitoon progressiivinen neurologiset oireet aikuisilla ja lapsilla, joilla oli niemann-pickin tyypin c tautia.
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
fentanyl 50 mikrog/ml injektioneste, liuos
piramal critical care b.v. - fentanyl citrate - injektioneste, liuos - 50 mikrog/ml - fentanyyli
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
sufenta 5 mikrog/ml injektioneste, liuos
piramal critical care b.v. - sufentanil citrate - injektioneste, liuos - 5 mikrog/ml - sufentaniili
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
sufenta forte 50 mikrog/ml injektioneste, liuos
piramal critical care b.v. - sufentanil citrate - injektioneste, liuos - 50 mikrog/ml - sufentaniili
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochloride - paksusuolen vajaatoiminta - antineoplastiset aineet - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
cytotec 0.2 mg tabletti
pfizer oy - misoprostol - tabletti - 0.2 mg - misoprostoli
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
voriconazole sandoz 50 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - voriconazolum - tabletti, kalvopäällysteinen - 50 mg - vorikonatsoli
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
voriconazole pfizer 50 mg tabletti, kalvopäällysteinen
pfizer oy pfizer oy - voriconazolum - tabletti, kalvopäällysteinen - 50 mg - vorikonatsoli
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
voriconazole pfizer 200 mg tabletti, kalvopäällysteinen
pfizer oy pfizer oy - voriconazolum - tabletti, kalvopäällysteinen - 200 mg - vorikonatsoli
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
voriconazole accordpharma 50 mg tabletti, kalvopäällysteinen
accord healthcare b.v. accord healthcare b.v. - voriconazolum - tabletti, kalvopäällysteinen - 50 mg - vorikonatsoli